Logo (Actavis) 855 (Guanfacine Hydrochloride Extended-Release 4 mg)
Pill with imprint Logo (Actavis) 855 is Yellow, Elliptical / Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Pharma, Inc..
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 855
Guanfacine Hydrochloride Extended-Release
- Imprint
- Logo (Actavis) 855
- Strength
- 4 mg
- Color
- Yellow
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2855 | Actavis Pharma, Inc. |
| 42291-0327 | AvKare, Inc. |
More about guanfacine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 237 Reviews
- Drug class: antiadrenergic agents, centrally acting
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
